Global Remote Patient Monitoring Systems Market to Reach $8.1 Billion by 2030

ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, March 07, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Remote Patient Monitoring Systems Industry" - https://www.reportlinker.com/p05818127/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Remote Patient Monitoring Systems Market to Reach $8.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Remote Patient Monitoring Systems estimated at US$2.1 Billion in the year 2022, is projected to reach a revised size of US$8.1 Billion by 2030, growing at aCAGR of 18.4% over the period 2022-2030. Special Monitors, one of the segments analyzed in the report, is projected to record 17.5% CAGR and reach US$6.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Vital Sign Monitors segment is readjusted to a revised 22.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $614 Million, While China is Forecast to Grow at 17.4% CAGR

The Remote Patient Monitoring Systems market in the U.S. is estimated at US$614 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 17.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 15.7% and 14.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.1% CAGR.

Select Competitors (Total 162 Featured)
- Biotronik SE & Co. KG
- F. Hoffmann-La Roche AG
- Intel Corporation
- Johnson & Johnson
- Koninklijke Philips NV
- Medtronic of Canada Ltd.
- Philips Healthcare
- Robert Bosch GmbH
- Welch Allyn, Inc.


Read the full report: https://www.reportlinker.com/p05818127/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Remote Patient Monitoring Systems - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Remote Patient Monitoring
Systems by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR

Table 3: World 16-Year Perspective for Remote Patient
Monitoring Systems by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets for Years 2014, 2023 &
2030

Table 4: World Recent Past, Current & Future Analysis for Vital
Sign Monitors by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 5: World Historic Review for Vital Sign Monitors by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 6: World 16-Year Perspective for Vital Sign Monitors by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Special Monitors by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 8: World Historic Review for Special Monitors by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 9: World 16-Year Perspective for Special Monitors by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Cancer by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 11: World Historic Review for Cancer by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Cancer by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Cardiovascular Diseases by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 14: World Historic Review for Cardiovascular Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 15: World 16-Year Perspective for Cardiovascular Diseases
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Diabetes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 17: World Historic Review for Diabetes by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for Diabetes by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Sleep Disorder by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 20: World Historic Review for Sleep Disorder by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 21: World 16-Year Perspective for Sleep Disorder by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 23: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 24: World 16-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for
Hospital based Patients by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 26: World Historic Review for Hospital based Patients by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 27: World 16-Year Perspective for Hospital based Patients
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 28: World Recent Past, Current & Future Analysis for
Ambulatory Patients by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 29: World Historic Review for Ambulatory Patients by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 30: World 16-Year Perspective for Ambulatory Patients by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 31: World Recent Past, Current & Future Analysis for Home
Healthcare by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 32: World Historic Review for Home Healthcare by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 33: World 16-Year Perspective for Home Healthcare by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 34: World Recent Past, Current & Future Analysis for
Hypertension by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 35: World Historic Review for Hypertension by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 36: World 16-Year Perspective for Hypertension by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 37: World Remote Patient Monitoring Systems Market
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2030

III. MARKET ANALYSIS

UNITED STATES
Remote Patient Monitoring Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2023 (E)
Table 38: USA Recent Past, Current & Future Analysis for Remote
Patient Monitoring Systems by Product Type - Special Monitors
and Vital Sign Monitors - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 39: USA Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 40: USA 16-Year Perspective for Remote Patient Monitoring
Systems by Product Type - Percentage Breakdown of Value Sales
for Special Monitors and Vital Sign Monitors for the Years
2014, 2023 & 2030

Table 41: USA Recent Past, Current & Future Analysis for Remote
Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 42: USA Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 43: USA 16-Year Perspective for Remote Patient Monitoring
Systems by Application - Percentage Breakdown of Value Sales
for Diabetes, Hypertension, Cancer, Cardiovascular Diseases,
Sleep Disorder and Other Applications for the Years 2014, 2023 &
2030

Table 44: USA Recent Past, Current & Future Analysis for Remote
Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 45: USA Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 46: USA 16-Year Perspective for Remote Patient Monitoring
Systems by End-Use - Percentage Breakdown of Value Sales for
Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

CANADA
Table 47: Canada Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Product Type - Special
Monitors and Vital Sign Monitors - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 48: Canada Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 49: Canada 16-Year Perspective for Remote Patient
Monitoring Systems by Product Type - Percentage Breakdown of
Value Sales for Special Monitors and Vital Sign Monitors for
the Years 2014, 2023 & 2030

Table 50: Canada Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 51: Canada Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 52: Canada 16-Year Perspective for Remote Patient
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular
Diseases, Sleep Disorder and Other Applications for the Years
2014, 2023 & 2030

Table 53: Canada Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 54: Canada Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 55: Canada 16-Year Perspective for Remote Patient
Monitoring Systems by End-Use - Percentage Breakdown of Value
Sales for Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

JAPAN
Remote Patient Monitoring Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 56: Japan Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Product Type - Special
Monitors and Vital Sign Monitors - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 57: Japan Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 58: Japan 16-Year Perspective for Remote Patient
Monitoring Systems by Product Type - Percentage Breakdown of
Value Sales for Special Monitors and Vital Sign Monitors for
the Years 2014, 2023 & 2030

Table 59: Japan Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 60: Japan Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 61: Japan 16-Year Perspective for Remote Patient
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular
Diseases, Sleep Disorder and Other Applications for the Years
2014, 2023 & 2030

Table 62: Japan Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 63: Japan Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 64: Japan 16-Year Perspective for Remote Patient
Monitoring Systems by End-Use - Percentage Breakdown of Value
Sales for Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

CHINA
Remote Patient Monitoring Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 65: China Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Product Type - Special
Monitors and Vital Sign Monitors - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 66: China Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 67: China 16-Year Perspective for Remote Patient
Monitoring Systems by Product Type - Percentage Breakdown of
Value Sales for Special Monitors and Vital Sign Monitors for
the Years 2014, 2023 & 2030

Table 68: China Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 69: China Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 70: China 16-Year Perspective for Remote Patient
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular
Diseases, Sleep Disorder and Other Applications for the Years
2014, 2023 & 2030

Table 71: China Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 72: China Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 73: China 16-Year Perspective for Remote Patient
Monitoring Systems by End-Use - Percentage Breakdown of Value
Sales for Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

EUROPE
Remote Patient Monitoring Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 74: Europe Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Geographic Region -
France, Germany, Italy, UK and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 75: Europe Historic Review for Remote Patient Monitoring
Systems by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 76: Europe 16-Year Perspective for Remote Patient
Monitoring Systems by Geographic Region - Percentage Breakdown
of Value Sales for France, Germany, Italy, UK and Rest of
Europe Markets for Years 2014, 2023 & 2030

Table 77: Europe Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Product Type - Special
Monitors and Vital Sign Monitors - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 78: Europe Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 79: Europe 16-Year Perspective for Remote Patient
Monitoring Systems by Product Type - Percentage Breakdown of
Value Sales for Special Monitors and Vital Sign Monitors for
the Years 2014, 2023 & 2030

Table 80: Europe Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 81: Europe Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 82: Europe 16-Year Perspective for Remote Patient
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular
Diseases, Sleep Disorder and Other Applications for the Years
2014, 2023 & 2030

Table 83: Europe Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 84: Europe Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 85: Europe 16-Year Perspective for Remote Patient
Monitoring Systems by End-Use - Percentage Breakdown of Value
Sales for Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

FRANCE
Remote Patient Monitoring Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 86: France Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Product Type - Special
Monitors and Vital Sign Monitors - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 87: France Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 88: France 16-Year Perspective for Remote Patient
Monitoring Systems by Product Type - Percentage Breakdown of
Value Sales for Special Monitors and Vital Sign Monitors for
the Years 2014, 2023 & 2030

Table 89: France Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 90: France Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 91: France 16-Year Perspective for Remote Patient
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular
Diseases, Sleep Disorder and Other Applications for the Years
2014, 2023 & 2030

Table 92: France Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 93: France Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 94: France 16-Year Perspective for Remote Patient
Monitoring Systems by End-Use - Percentage Breakdown of Value
Sales for Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

GERMANY
Remote Patient Monitoring Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 95: Germany Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Product Type - Special
Monitors and Vital Sign Monitors - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 96: Germany Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 97: Germany 16-Year Perspective for Remote Patient
Monitoring Systems by Product Type - Percentage Breakdown of
Value Sales for Special Monitors and Vital Sign Monitors for
the Years 2014, 2023 & 2030

Table 98: Germany Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 99: Germany Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 100: Germany 16-Year Perspective for Remote Patient
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular
Diseases, Sleep Disorder and Other Applications for the Years
2014, 2023 & 2030

Table 101: Germany Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 102: Germany Historic Review for Remote Patient
Monitoring Systems by End-Use - Hospital based Patients,
Ambulatory Patients and Home Healthcare Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR

Table 103: Germany 16-Year Perspective for Remote Patient
Monitoring Systems by End-Use - Percentage Breakdown of Value
Sales for Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

ITALY
Table 104: Italy Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Product Type - Special
Monitors and Vital Sign Monitors - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 105: Italy Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 106: Italy 16-Year Perspective for Remote Patient
Monitoring Systems by Product Type - Percentage Breakdown of
Value Sales for Special Monitors and Vital Sign Monitors for
the Years 2014, 2023 & 2030

Table 107: Italy Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 108: Italy Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 109: Italy 16-Year Perspective for Remote Patient
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular
Diseases, Sleep Disorder and Other Applications for the Years
2014, 2023 & 2030

Table 110: Italy Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 111: Italy Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 112: Italy 16-Year Perspective for Remote Patient
Monitoring Systems by End-Use - Percentage Breakdown of Value
Sales for Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

UNITED KINGDOM
Remote Patient Monitoring Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United Kingdom
for 2023 (E)
Table 113: UK Recent Past, Current & Future Analysis for Remote
Patient Monitoring Systems by Product Type - Special Monitors
and Vital Sign Monitors - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 114: UK Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 115: UK 16-Year Perspective for Remote Patient Monitoring
Systems by Product Type - Percentage Breakdown of Value Sales
for Special Monitors and Vital Sign Monitors for the Years
2014, 2023 & 2030

Table 116: UK Recent Past, Current & Future Analysis for Remote
Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 117: UK Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 118: UK 16-Year Perspective for Remote Patient Monitoring
Systems by Application - Percentage Breakdown of Value Sales
for Diabetes, Hypertension, Cancer, Cardiovascular Diseases,
Sleep Disorder and Other Applications for the Years 2014, 2023 &
2030

Table 119: UK Recent Past, Current & Future Analysis for Remote
Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 120: UK Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 121: UK 16-Year Perspective for Remote Patient Monitoring
Systems by End-Use - Percentage Breakdown of Value Sales for
Hospital based Patients, Ambulatory Patients and Home

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05818127/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001